Posted by: All About MS | December 12, 2009

Study – Copaxone plus estriol

Specific Study Information
The Rocky Mountain MS Center at Anschutz Medical Campus is looking for women with relapsing remittingĀ MS for a 24 -month study to see if there are fewer relapses with the treatment of
Copaxone injections plus oral estriol as compared to the treatment of Copaxone injections plus oral
placebo. There will be no patients receiving only placebo in this trial. They will all receive Copaxone.
To be eligible for this study you must:
Be female, between 18 and 50 years old;
Be diagnosed with definite RRMS.
Be able to walk without any aids such as cane or walker;
Have had at least one relapse within the last 2 years;
Be able to travel to the Rocky Mountain MS Center at Anschutz Medical Campus for a
number of study visits.
You are not eligible for the study if you are pregnant, breast-feeding, smoke, or have other serious
medical conditions. Previous treatment with Copaxone or an interferon (Avonex, Rebif,
Betaseron) are allowed.
If you are interested in this study in particular, please email neurology.msresearch@ucdenver.edu
or call 303-724-4644 for further information and a 20-minute telephone screening to determine
initial eligibility for the study.

Specific Study InformationThe Rocky Mountain MS Center at Anschutz Medical Campus is looking for women with relapsingremittingMS for a 24 -month study to see if there are fewer relapses with the treatment ofCopaxone injections plus oral estriol as compared to the treatment of Copaxone injections plus oralplacebo. There will be no patients receiving only placebo in this trial. They will all receive Copaxone.To be eligible for this study you must:Be female, between 18 and 50 years old;Be diagnosed with definite RRMS.Be able to walk without any aids such as cane or walker;Have had at least one relapse within the last 2 years;Be able to travel to the Rocky Mountain MS Center at Anschutz Medical Campus for anumber of study visits.You are not eligible for the study if you are pregnant, breast-feeding, smoke, or have other seriousmedical conditions. Previous treatment with Copaxone or an interferon (Avonex, Rebif,Betaseron) are allowed.If you are interested in this study in particular, please email neurology.msresearch@ucdenver.eduor call 303-724-4644 for further information and a 20-minute telephone screening to determineinitial eligibility for the study.

Advertisements

Responses

  1. I am a 35 year old female and was recently diagnosed with RRMS. Prior to diagnosis I considered myself to be healthy- I have a low fat diet, exercise regularly and have a good relationship with my family. I am a college graduate with a masters degree in education. Being diagnosed has changed my life drastically but I am being proactive and keeping a positive outlook about my future. I would like to be a participant in this study because finding a cure will greatly impact my life and the other 2.5 million people in the world living with MS.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Categories

%d bloggers like this: